MEDIC-IMMO: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MEDIC-IMMO
Largest movements
- Tangible fixed assets +€781,834
up €781,834 (+1843.2%), from €42,417 to €824,251
- Receivables within one year +€126,606
up €126,606 (+421.3%), from €30,050 to €156,656
of which Trade receivables: +€107,461
- Debts after one year +€758,923
new in 2025: €758,923
- Trade debts +€192,939
up €192,939 (+25072.1%), from €770 to €193,709
- Profit (loss) carried forward -€51,073
down €51,073 (-176.8%), from -€28,886 to -€79,959
- Financial charges +€21,078
up €21,078 (+11384.3%), from €185 to €21,263
- Depreciation +€10,399
up €10,399 (+206.7%), from €5,031 to €15,430
- Gross operating margin +€9,087
up €9,087 (+39.8%), from -€22,836 to -€13,749
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €221,884 | €1,126,078 | +€904,194 | +407.5% |
| Fixed assets | 21/28 | €42,417 | €824,251 | +€781,834 | +1843.2% |
| Tangible fixed assets | 22/27 | €42,417 | €824,251 | +€781,834 | +1843.2% |
| Land and buildings | 22 | €42,417 | €824,251 | +€781,834 | +1843.2% |
| Current assets | 29/58 | €179,467 | €301,827 | +€122,360 | +68.2% |
| Amounts receivable within one year | 40/41 | €30,050 | €156,656 | +€126,606 | +421.3% |
| Trade receivables | 40 | €30,000 | €137,461 | +€107,461 | +358.2% |
| Other amounts receivable | 41 | €50 | €19,195 | +€19,145 | +38313.2% |
| Cash at bank and in hand | 54/58 | €149,417 | €142,047 | -€7,370 | -4.9% |
| Deferred charges and accrued income | 490/1 | - | €3,124 | +€3,124 | |
| Total equity and liabilities | 10/49 | €221,884 | €1,126,078 | +€904,194 | +407.5% |
| Equity | 10/15 | €221,114 | €170,041 | -€51,073 | -23.1% |
| Contributions | 10/11 | €250,000 | €250,000 | = | 0.0% |
| Outside capital | 11 | €250,000 | €250,000 | = | 0.0% |
| Other | 1109/19 | €250,000 | €250,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€28,886 | -€79,959 | -€51,073 | -176.8% |
| Amounts payable | 17/49 | €770 | €956,037 | +€955,268 | +124134.9% |
| Amounts payable after more than one year | 17 | - | €758,923 | +€758,923 | |
| Financial debts | 170/4 | - | €758,923 | +€758,923 | |
| Amounts payable within one year | 42/48 | €770 | €194,361 | +€193,592 | +25156.8% |
| Trade debts | 44 | €770 | €193,709 | +€192,939 | +25072.1% |
| Suppliers | 440/4 | €770 | €193,709 | +€192,939 | +25072.1% |
| Taxes, remuneration and social security | 45 | - | €652 | +€652 | |
| Taxes | 450/3 | - | €652 | +€652 | |
| Accrued charges and deferred income | 492/3 | - | €2,753 | +€2,753 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €5,031 | €15,430 | +€10,399 | +206.7% |
| Other operating charges | 640/8 | €834 | €632 | -€202 | -24.2% |
| Gross operating margin | 9900 | -€22,836 | -€13,749 | +€9,087 | +39.8% |
| Operating profit (loss) | 9901 | -€28,701 | -€29,810 | -€1,110 | -3.9% |
| Financial charges | 65/66B | €185 | €21,263 | +€21,078 | +11384.3% |
| Recurring financial charges | 65 | €185 | €21,263 | +€21,078 | +11384.3% |
| Profit (loss) for the period before taxes | 9903 | -€28,886 | -€51,073 | -€22,188 | -76.8% |
| Profit (loss) for the period | 9904 | -€28,886 | -€51,073 | -€22,188 | -76.8% |
| Profit (loss) for the period to be appropriated | 9905 | -€28,886 | -€51,073 | -€22,188 | -76.8% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 1 October 2026 via checked.be.